According to Lipocine's latest financial reports the company's current EPS (TTM) is -$3.06. In 2022 the company made an earnings per share (EPS) of -$2.81 a decrease over its 2021 EPS that were of -$0.24.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.98 | 6.08% |
2022 | -$2.81 | 1094.12% |
2021 | -$0.24 | -97.5% |
2020 | -$9.41 | -20% |
2019 | -$11.76 | -9.09% |
2018 | -$12.94 | -47.12% |
2017 | -$24.46 | -0% |
2016 | -$24.46 | -4.93% |
2015 | -$25.73 | -31.63% |
2014 | -$37.63 | 74.47% |
2013 | -$21.57 | -99.35% |
2012 | -$3,309 |